Total Payments
$10,985
2024 Payments
$5,373
Companies
30
Transactions
237
Medicare Patients
2,838
Medicare Billing
$245,262
Payment Breakdown by Category
Food & Beverage$5,245 (47.8%)
Education$4,194 (38.2%)
Travel$1,545 (14.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,245 | 223 | 47.8% |
| Education | $4,194 | 6 | 38.2% |
| Travel and Lodging | $1,545 | 8 | 14.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $5,670 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $898.46 | 32 | $0 (2024) |
| GlaxoSmithKline, LLC. | $865.16 | 43 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $732.09 | 18 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $696.79 | 24 | $0 (2024) |
| United Therapeutics Corporation | $316.46 | 11 | $0 (2024) |
| Mylan Specialty L.P. | $254.01 | 15 | $0 (2023) |
| Insmed, Inc. | $175.11 | 11 | $0 (2024) |
| Merck Sharp & Dohme LLC | $174.63 | 11 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $159.55 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,373 | 39 | INTUITIVE SURGICAL, INC. ($4,751) |
| 2023 | $2,211 | 49 | Intuitive Surgical, Inc. ($918.66) |
| 2022 | $1,442 | 64 | Regeneron Healthcare Solutions, Inc. ($312.15) |
| 2021 | $1,090 | 48 | GlaxoSmithKline, LLC. ($214.88) |
| 2020 | $479.05 | 26 | AstraZeneca Pharmaceuticals LP ($155.47) |
| 2019 | $142.33 | 5 | GlaxoSmithKline, LLC. ($127.37) |
| 2018 | $83.00 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($83.00) |
| 2017 | $164.30 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($90.48) |
All Payment Transactions
237 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Pulmonology | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Respiratory | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Respiratory | ||||||
| 07/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: DIABETES | ||||||
| 07/24/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Immunology | ||||||
| 07/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: RESPIRATORY | ||||||
| 07/03/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Pulmonology | ||||||
| 07/02/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/24/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $33.97 | General |
| Category: Heart Failure and Hypertension | ||||||
| 06/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: RESPIRATORY | ||||||
| 06/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Respiratory | ||||||
| 05/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/23/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 04/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: DIABETES | ||||||
| 04/17/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Pulmonology | ||||||
| 04/12/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $1,500.00 | General |
| Category: SURGERY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 615 | 788 | $109,352 | $53,818 |
| 2022 | 14 | 712 | 944 | $116,566 | $59,357 |
| 2021 | 16 | 728 | 974 | $126,337 | $64,906 |
| 2020 | 15 | 783 | 1,100 | $151,539 | $67,182 |
Total Patients
2,838
Total Services
3,806
Medicare Billing
$245,262
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 186 | 284 | $41,516 | $24,687 | 59.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 177 | 232 | $22,988 | $13,168 | 57.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $12,014 | $5,915 | 49.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 24 | $7,149 | $3,152 | 44.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 40 | $4,211 | $2,396 | 56.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 25 | 26 | $10,190 | $2,249 | 22.1% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 16 | 16 | $5,794 | $1,413 | 24.4% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 38 | 38 | $1,201 | $326.35 | 27.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 37 | 37 | $2,046 | $235.10 | 11.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 28 | 28 | $1,816 | $202.32 | 11.1% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 12 | 12 | $427.00 | $73.92 | 17.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 183 | 303 | $42,944 | $26,455 | 61.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 181 | 251 | $24,262 | $15,263 | 62.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $10,975 | $5,717 | 52.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 25 | 26 | $9,790 | $2,380 | 24.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 20 | $4,188 | $2,061 | 49.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 21 | 21 | $7,358 | $1,923 | 26.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 27 | $2,748 | $1,463 | 53.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 27 | 27 | $2,538 | $1,112 | 43.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 27 | 27 | $2,997 | $1,018 | 34.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 14 | 14 | $1,426 | $388.64 | 27.3% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2022 | 11 | 11 | $1,813 | $376.63 | 20.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 34 | 34 | $1,031 | $313.53 | 30.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 13 | 13 | $738.00 | $249.03 | 33.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 34 | 34 | $1,652 | $232.56 | 14.1% |
About Dr. Khalid Khan, MD
Dr. Khalid Khan, MD is a Pulmonary Disease healthcare provider based in Cape Girardeau, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851475669.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khalid Khan, MD has received a total of $10,985 in payments from pharmaceutical and medical device companies, with $5,373 received in 2024. These payments were reported across 237 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($5,245).
As a Medicare-enrolled provider, Khan has provided services to 2,838 Medicare beneficiaries, totaling 3,806 services with total Medicare billing of $245,262. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Cape Girardeau, MO
- Active Since 10/25/2006
- Last Updated 01/15/2008
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851475669
Products in Payments
- Da Vinci Surgical System (Device) $5,670
- DUPIXENT (Biological) $767.49
- OFEV (Drug) $341.13
- AIRSUPRA (Drug) $296.34
- TRELEGY ELLIPTA (Drug) $288.41
- NUCALA (Biological) $287.01
- Yupelri (Drug) $221.08
- FASENRA (Biological) $189.93
- TYVASO (Drug) $182.84
- Arikayce (Drug) $175.11
- AREXVY (Drug) $171.49
- TEZSPIRE (Biological) $166.98
- ACTHAR (Biological) $159.55
- SPIRIVA RESPIMAT (Drug) $157.16
- BREZTRI (Drug) $140.72
- ORENITRAM (Drug) $133.62
- BREZTRI AEROSPHERE (Drug) $126.79
- Prolastin-C Liquid (Biological) $117.09
- Wakix (Drug) $110.88
- ANORO ELLIPTA (Drug) $100.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.